JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 57(2023) N 6 p. 1143-1164; DOI 10.1134/S0026893323060067 Full Text

R.G. Goncharov1, M.G. Sharapov1*

Ischemia-Reperfusion Injury: Molecular Mechanisms of Pathogenesis and Methods of Their Correction

1Institute of Cell Biophysics, Russian Academy of Sciences, Pushchino, Moscow oblast, 142290 Russia

*sharapov.mg@yandex.ru
Received - 2023-04-10; Revised - 2023-05-09; Accepted - 2023-05-10

Ischemia-reperfusion is a cascade of complex and interrelated pathological processes underlying many human diseases, including such socially significant diseases as stroke, myocardial infarction, acute renal failure, etc. The present review considers modern ideas about the main biochemical and signal-regulatory processes in the cell under conditions of ischemia-reperfusion. Both generally accepted and newly developed ways of ischemia-reperfusion lesion correction aimed at different chains of this pathological process are considered.

ischemia-reperfusion, oxidative stress, intracellular signaling, HIF, NRF2, NF-κB, PI3K/AKT/mTOR, hypothermia, oxidase inhibitors, H2S, antioxidants, selenium, mimetics, antioxidant enzymes



JMB-FOOTER RAS-JOURNALS